ORBIMED ADVISORS LLC SpringWorks Therapeutics, Inc. Transaction History

ORBIMED ADVISORS LLC portfolio value:

$157.65M
portfolio value

ORBIMED ADVISORS LLC quarter portfolio value change:

+15.88%
quarter

SpringWorks Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -8.33% -502.38K shares 9.23M $28.53 5.52M
Q2 2022 share 0.00% 0 shares -191.82M $24.62 6.02M
Q1 2022 share 0.00% 0 shares -33.39M $56.44 6.02M
Q4 2021 share 0.00% 0 shares -8.80M $62.33 6.02M
Q3 2021 share Decrease -0.26% -15.95K shares -115.67M $63.44 6.02M
Q2 2021 share Decrease -2.30% -142.04K shares 42.98M $82.41 6.04M
Q1 2021 share Decrease -16.47% -1.22M shares -81.97M $73.57 6.18M
Q4 2020 share 0.00% 0 shares 184.04M $72.52 7.40M
Q3 2020 share 0.00% 0 shares 41.99M $47.67 7.40M
Q2 2020 share 0.00% 0 shares 111.09M $42 7.40M
Q1 2020 share 0.00% 0 shares -85.09M $27 7.40M
Q4 2019 share 0.00% 0 shares 124.5M $38.49 7.40M
Q3 2019 share Increase 0.00% 7.40M shares 160.56M $21.68 7.40M